The latest statistics of the Ministry of Commerce show that the scale of China's drug circulation market has maintained a steady growth trend, with the continuous deepening of medical reform, the competitive situation and policy environment of the drug circulation industry are constantly changing, and strategic opportunities and risks coexist. All parties in the industry must maintain a high level of coordination, pursue high-quality development, further promote the construction of modern supply chain system, accelerate the pace of digital & intelligent transformation, promote cost reduction and efficiency and business model innovation, embrace sustainability to realize the optimization and upgrading of the entire pharmaceutical supply chain network and the transformation of the pharmaceutical value chain.Topics include supply chainsustainability, risk management, business continuity plan,resilience and agility, E2E visibility, logistics model transformation, cost efficiency, temperature control operations, demand forecasting & planning, digital tool application, intelligent decision-making, operational excellence, upstream & downstream collaboration, new supply chain talent and work model innovation…have become the focus of attention.